The Radiation Oncology Division offers state-of-the-art planning and treatment for cancer, including 3-D modulation and brachytherapy.

Brachytherapy
The Urologic Oncology Division works closely with Radiation Oncology facilitating the brachytherapy program for prostate cancer. Brachytherapy, also called internal radiation, is an advanced cancer treatment that utilizes radioactive seeds or sources by placing them in or near the tumor itself. This enables a high dose of radiation to the tumor while reducing the radiation exposure to healthy tissue.

Brachytherapy delivers a highly concentrated dose of radiation near or in the tumor, while sparing the surrounding healthy tissue. Also called, radiation implant or a radioactive source. It may be used alone or in combination with other radiation therapy procedures. Brachytherapy treatment may be delivered in the form of small seeds (such as prostate seed implants) or wires that are placed inside the tumor (HDR). Brachytherapy may be delivered in a high dose or a low dose. The dose of radiation through brachytherapy depends on the size of the tumor, location and the sensitivity to radiation.